Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

BioBlocks describes new anticancer compounds

July 12, 2010

Cellceutix completes animal safety pharmacology studies required by FDA

July 9, 2010

New apoptosis-inducing agents discovered at Brock University

July 9, 2010

Intratumoral TG-4023 gene therapy is feasible in patients with liver cancer

July 9, 2010

New tyrosine kinase inhibitors claimed by Merck KGaA

July 8, 2010

Molecular Templates and ImClone enter oncology research collaboration

July 8, 2010

Enzastaurin shows potential in phase II follicular lymphoma trial

July 8, 2010

Phase I data reported on PCI-32765 in non-Hodgkin's lymphoma

July 8, 2010

Best response of stable disease seen in phase I BI-811283 trial in solid tumors

July 8, 2010

NIH awards grant to Dynavax to develop universal HPV vaccine

July 7, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 4, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...